Evidence map›Paper›PMID 42591806›Full record

ArticleFrontiers in cardiovascular medicine2026

Time-critical VA-ECMO-facilitated resuscitation and recovery after acute myocardial infarction with cardiogenic shock and cardiac arrest: a case report.

Zhiqiang Wang, Yaliang Tong, Yi Gao, Guohui Liu, Yingying Su, Kenji Wagatsuma, Junru Qu, Beibei Du, Yuquan He

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhiqiang Wang *Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Yaliang Tong *Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Yi GaoDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Guohui LiuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Yingying SuChangchun University of Chinese Medicine, Changchun, China.
Kenji WagatsumaTokyo D Tower Hospital, Tokyo, Japan.
Junru QuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Beibei DuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.
Yuquan HeDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Cardiovascular Research Institute, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiogenic shock (CS) in the setting of acute myocardial infarction (AMI) remains associated with poor prognosis, with mortality of approximately 40%-50% despite mechanical circulatory support (MCS). Its prognostic value remains uncertain because AMI with CS involves complex pathophysiology requiring consideration of implantation timing, organ protection, functional recovery, and prevention of device-related and critical illness-related complications. Case summary: A 36-year-old man with diabetes and hypertension was readmitted with recurrent chest pain 6 months after coronary stent implantation for acute anterior AMI. Initial electrocardiographic findings and rapid hemodynamic deterioration supported AMI complicated by CS. During emergency percutaneous coronary intervention, he developed refractory ventricular fibrillation (VF)/cardiac arrest (CA). Because the arrest occurred under in-hospital monitoring, chest compressions were initiated immediately, resulting in a no-flow interval of 0 min. A multidisciplinary extracorporeal cardiopulmonary resuscitation (ECPR) response was activated, and effective veno-arterial extracorporeal membrane oxygenation (VA-ECMO) flow was established 20 min after activation during ongoing cardiopulmonary resuscitation (CPR). This constituted ECPR rather than VA-ECMO after stable return of spontaneous circulation (ROSC), allowing right coronary artery revascularization with TIMI grade 3 flow. After VA-ECMO initiation, the early post-resuscitation course was complicated by weak arterial pulsatility, restricted aortic valve opening, persistent hyperlactatemia, pneumonia/airway infection, transient hyperosmolar disturbance, and suspected post-arrest hypoxic-ischemic encephalopathy. With multidisciplinary management, cardiac function improved, organ dysfunction partially recovered, and the patient was discharged on day 10 with a favorable neurological outcome, defined as Cerebral Performance Category (CPC) grade 1 and modified Rankin Scale (mRS) score 0. At 1 year, follow-up confirmed sustained functional recovery, patent previous stenting without significant restenosis, no progression of other coronary lesions, return to normal quality of life, and persistently favorable neurological status (CPC 1; mRS 0). Conclusion: This case highlights the value of program-level ECPR readiness in selected patients with monitored AMI-related refractory CA during emergency percutaneous coronary intervention. A pre-primed ECMO pathway, immediate CPR, 0 min no-flow exposure, 20 min ECPR activation-to-flow interval, completed coronary reperfusion, and complication-focused multidisciplinary care contributed to this outcome. As a single case, these findings should be interpreted as hypothesis-generating rather than supporting unselective VA-ECMO use in AMI complicated by CS.

Indexed as

acute myocardial infarction (AMI)cardiac arrest (CA)cardiogenic shock (CS)mechanical circulatory support (MCS)multidisciplinary managementveno-arterial extracorporeal membrane oxygenation (VA-ECMO)

Identifiers

PMID42591806
PMCPMC13462042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.